Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Fig. 5 | Breast Cancer Research

Fig. 5

From: Oral metronomic vinorelbine combined with endocrine therapy in hormone receptor-positive HER2-negative breast cancer: SOLTI-1501 VENTANA window of opportunity trial

Fig. 5

Global gene expression changes induced by each arm from baseline to surgery. a Heatmaps showing differential expression of 49 selected genes and gene signatures at 3 weeks in each arm. b 360° view summarizing the gene/signatures for the breast tumor microenvironment and immune response in LTZ+mVNB arm between baseline and surgery. c Venn diagram showing the overlap in the list of differentially expressed genes obtained in the before and after treatment across the comparisons of the three arms

Back to article page